Les 10 concurrents nesa.world les plus visités

neolifesalud.com

Suitability for joining an age management programme At what age is it no longer worth starting an anti-ageing medicine programme? The sooner you start an anti-ageing preventive medicine or age management programme, the better. Although, from 30 years on, and more markedly in the 40s, is when signs of ageing start to appear significantly. At […]

electrocore.com

PRESTO demonstrates clinical benefit of gammaCore in the acute treatment of migraine compared to sham Basking Ridge, NJ, September 11, 2017 – electroCore, a neuroscience and technology company dedicated to improving patient outcomes through technological advancement, announced the first results from the PRESTO (The PRospectivE Study of nVNS for the Acute Treatment Of Migraine) clinical trial evaluating the use of gammaCore® (non-invasive vagus nerve stimulator) in migraine at the 18th Congress of the International Headache Society (IHC). Findings from the study “Non-invasive Vagus Nerve Stimulation (nVNS) for the Acute Treatment of Migraine: A Randomized Controlled Trial” (IHC Abstract OC-LB-002) were presented on Saturday, September 9 as a late-breaking oral presentation. “Migraine is the third most common disease in the world,[i] and one of the 10 most disabling diseases, which highlights a need for novel treatment options,” said Dr. Cristina Tassorelli, Director of the Headache Science Centre, National Neurological Institute C. Mondino Foundation;  Professor at the University of Pavia, Pavia, Italy; and principal trial investigator. “The PRESTO data suggests that gammaCore was rapidly effective, well tolerated and practical for the acute treatment of episodic migraine. The data supports the use of gammaCore to successfully treat a migraine, making the device a...

nevro.com

We Believe True Innovation Transforms More Lives

ionclinics.com

Política de Calidad Descargar La dirección de IONCLINICS & DEIONIC, S.L. proclama la siguiente declaración de “Política de Calidad”, y se compromete a difundirla y hacerla entender en toda la empresa y en lo que proceda a sus clientes y proveedores, además de revisarla y mantenerla continuamente adecuada. La Dirección de IONCLINICS & DEIONIC, S.L . quiere […]

zapper-pro.si

zapper-pro Pomembne Frekvence -

dbs-chiryo.jp

パーキンソン病とはどんな病気でしょうか。このサイトでは、薬による治療をはじめ、パーキンソン病の手術治療dbs（脳深部刺激療法）の効果や手術内容、副作用ついてご説明や、dbs手術が受けられる病院を掲載しています。

coherenceneuro.com

Our Cofounder and CEO, Ben Woodington, sits down with Brom Rector of XEIA ventures to discuss the future of neurotechnology and the huge opportunity in helping patients with brain cancer

nirx.net

1. What is the penetration limit for fNIRS in tissue? / How deep can one probe with NIRS? 2. What is the achievable spatial resolution of NIRS? 3. What is the temporal resolution of NIRS? 4. Can you provide user references for your NIRS systems and software? 5. What types of scientific investiga

optunegio.com

The most common side effects of Optune Gio®, which is a wearable device used as part of glioblastoma (GBM) treatments, are skin irritation and headaches

schmerz-spezialisten.de

Rückenmarkstimulation von Boston Scientific kann eine umfassende Lösung zur Behandlung chronischer Schmerzen sein.